The Hyderabad-based company claimed that BBV154 is proven to be safe, well-tolerated and immunogenic in the subjects under controlled clinical trials
The Health Security Agency said authorities are reporting about 29 new monkeypox infections every day, compared to about 52 cases a day during the last week in June.
British authorities also said that they bought as many as 150,000 doses of the vaccine, which was made by Bavarian Nordic, the world's only supplier
SII is working with Novavax to bring the Omicron-specific vaccine, as the nation continues to record a surge in the number of Covid-19 cases
ICMR has received 31 bids from manufacturers showing interest in developing vaccine and diagnostic kits against the monkeypox virus after the medical body floated the Expression of Interest (EOI)
Plans afoot to seek regulator nod for universal boosters
There are no discussions with the private sector because all available doses have already been bought by countries, he said.
Health ministry nod to the Biological E vaccine as 3rd dose after Covishield or Covaxin, CoWIN to be updated within a week
The Pune-based company that manufactured the Covid-19 vaccine administered to most Indians is exploring more sophisticated delivery systems
India's Vaccine Growth Story: From Cowpox to Vaccine Maitri is divided into nine chapters with an epilogue
With non-endemic countries reporting a rampant spike in the number of monkeypox cases, WHO on July 24, 2022, declared monkeypox a global health emergency
Adar Poonawalla has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, he tells about his plans for mass production of vaccines and more
The Union health ministry issued the 'Guidelines on Management of Monkeypox Disease' and stated that human-to-human transmission occurs primarily through large respiratory droplets
Poonawalla is learnt to have briefed Union Health Minister Mansukh Mandaviya on the subject during a meeting at the Nirman Bhawan here on Tuesday.
Upon being asked in the Rajya Sabha about the progress of vaccines for the disease, the Health Minister said that studies are still being conducted to find proper vaccination for the disease.
Due to the constantly emerging new Covid-19 variants, the currently available vaccines may not be as effective
Centre has formed a task force in the wake of Monkeypox cases in India to monitor and provide guidance to the government on the expansion of diagnostic facilities and to explore vaccination
Analysis shows that by September 29, the country will cover 28.6 per cent of the eligible population of 796 million who will be due for the booster dose
Moves by rich countries to buy large quantities of monkeypox vaccine, while declining to share doses with Africa, could leave millions of people unprotected
"We are now getting to 'wet' pathology tests like blood tests etc and we have set up a centre which will have minimal human intervention and maximum automation